RED MAMMOTH 400 mg Capsules Recalled for Undeclared Active Pharmaceutical Ingredients
RED MAMMOTH capsules, 400 mg (Lot # DK1027, Exp. 08/01/2023) are being recalled because they contain undeclared sildenafil and tadalafil, making them an unapproved drug marketed without FDA authorization.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is classified as FDA Class I. The source text states the product was "marketed without an Approved NDA/ANDA," which is the agency's own Class I designation. Per the severity rubric, FDA Class I recalls must receive a score of at least 4.
Plain-English summary
RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton (ASIN B00KA8FBNI, barcode X001ANE0I5), are being recalled by Celebrate Today, the manufacturer.
The product was found to contain undeclared sildenafil and tadalafil, active ingredients found in FDA-approved products for male sexual enhancement. Because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), it is classified as an unapproved drug.
The affected product (Lot # DK1027, Exp. 08/01/2023) was distributed nationwide in the USA via Amazon Marketplace. Consumers who have purchased this product should stop use immediately and consult a healthcare provider if they have any health concerns.
The recalled product
- Product
- RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI, barcode X001ANE0I5.
- Manufacturer
- Celebrate Today
- Category
- Drug — Unapproved Drug
- Hazard
- undeclared-sildenafil
- undeclared-tadalafil
- unapproved-drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # DK1027
- Exp. 08/01/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27